These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15638235)

  • 1. Polyunsaturated fatty acids (n-3 PUFAs) and inflammatory bowel disease (IBD): pathogenesis and treatment.
    Belluzzi A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):225-9. PubMed ID: 15638235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-3 fatty acids for the treatment of inflammatory bowel diseases.
    Belluzzi A
    Proc Nutr Soc; 2002 Aug; 61(3):391-5. PubMed ID: 12296296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.
    Calder PC
    Mol Nutr Food Res; 2008 Aug; 52(8):885-97. PubMed ID: 18504706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease.
    Klotz U; Schwab M
    Adv Drug Deliv Rev; 2005 Jan; 57(2):267-79. PubMed ID: 15555742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil.
    Brunborg LA; Madland TM; Lind RA; Arslan G; Berstad A; Frøyland L
    Clin Nutr; 2008 Aug; 27(4):614-22. PubMed ID: 18374458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer.
    Serini S; Piccioni E; Merendino N; Calviello G
    Apoptosis; 2009 Feb; 14(2):135-52. PubMed ID: 19130233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Imbalance between n-6/n-3 Polyunsaturated Fatty Acids and Inflammatory Bowel Disease: A Comprehensive Review and Future Therapeutic Perspectives.
    Scaioli E; Liverani E; Belluzzi A
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29206211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis.
    Li Q; Zhang Q; Zhang M; Wang C; Zhu Z; Li N; Li J
    FEBS J; 2008 Feb; 275(3):411-20. PubMed ID: 18167140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining nutrition, food science and engineering in developing solutions to Inflammatory bowel diseases--omega-3 polyunsaturated fatty acids as an example.
    Ferguson LR; Smith BG; James BJ
    Food Funct; 2010 Oct; 1(1):60-72. PubMed ID: 21776456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].
    Dejaco C; Haas T; Kirchgatterer A; Miehsler W; Wenzl H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W; Tilg H
    Z Gastroenterol; 2006 Jun; 44(6):525-38; discussion 539. PubMed ID: 16773519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis.
    Spiteller G
    Mol Nutr Food Res; 2005 Nov; 49(11):999-1013. PubMed ID: 16270286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease.
    Ueda Y; Kawakami Y; Kunii D; Okada H; Azuma M; Le DS; Yamamoto S
    Nutr Res; 2008 Apr; 28(4):239-44. PubMed ID: 19083414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Siddique I; Hasan F; Khan I
    Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polyunsaturated fatty acids and their metabolites in chronic inflammatory bowel disease].
    Cabré i Gelada E; Esteve i Comas M
    Gastroenterol Hepatol; 1995 Dec; 18(10):515-25. PubMed ID: 8548588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.